General·International Regulations·WADA
2012 Prohibited List
- In force from
- 2012/01/01
The 2012 Prohibited List, in force from 1 January 2012; the document that determines which substances and which methods were prohibited for athletes during that period.
| In force from | 1 January 2012 |
| Publication | World Anti-Doping Agency — 2012 List |
| Structure | International Standard — Prohibited List, 2012 edition |
| Status | Superseded — replaced by the 2013 List |
What is the Prohibited List?
The Prohibited List is one of the binding International Standards of the global anti-doping system and determines which substances and which methods are prohibited. Its structure has three parts: substances prohibited at all times (the S classes, together with the M methods), substances prohibited in-competition only, and substances prohibited in particular sports (class P). Alongside the List sits the Monitoring Programme: substances that are under surveillance but are not treated as prohibited. The World Anti-Doping Agency reviews and publishes this List at least once a year.
About the 2012 editionChanges from the 2011 edition
Key changes from the previous edition
- Scope and structureThis List separates three categories: substances and methods prohibited at all times, substances prohibited in-competition only, and substances prohibited in particular sports. Alongside them sits the Monitoring Programme, which covers substances under surveillance without their being prohibited.
- Relationship with the CodeThis List is published under the World Anti-Doping Code, and the criteria for a substance's inclusion in it are likewise determined in the Code itself. Use of a substance appearing on this List is an anti-doping rule violation even without intent to enhance performance, unless a valid Therapeutic Use Exemption exists.
Who this document matters to
In any doping case, the first question is whether the substance detected was prohibited under the List in force on the date of sample collection — and because this List changes every year, the answer depends on the edition that governed on that day; for that reason the earlier editions are retained on this page. For the team physician too, distinguishing "prohibited at all times" from "prohibited in-competition" and consulting the Monitoring Programme is essential before prescribing any medication. The official text is published in English and French and, in the event of any conflict, the English text prevails.